TRAF2 phosphorylation promotes NF-κB-dependent gene expression and inhibits oxidative stress-induced cell death

Molecular Biology of the Cell

Volumn 22, Issue 1, 2011, Pages 128-140

  Zhang, Laiqun ^a   Blackwell, Ken ^a   Altaeva, Aliya ^a   Shi, Zhaohui ^a   Habelhah, Hasem ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; I KAPPA B KINASE INHIBITOR; INHIBITOR OF APOPTOSIS PROTEIN 1; PROTEIN BCL 2; SERINE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ARTICLE; B CELL LYMPHOMA; CANCER CELL; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; STABLE EXPRESSION;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HELA CELLS; HUMANS; I-KAPPA B KINASE; IMMUNOBLOTTING; INHIBITOR OF APOPTOSIS PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MUTATION; NF-KAPPA B; NIH 3T3 CELLS; OXIDATIVE STRESS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2;

EID: 78651084030     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-06-0556     Document Type: Article

References (52)

1. Aggarwal BB (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6, 203-208.
2. Annunziata CM et al. (2007). Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12, 115-130.
3. Blackwell K, Zhang L, Thomas GS, Sun S, Nakano H, Habelhah H (2009). TRAF2 phosphorylation modulates tumor necrosis factor alpha-induced gene expression and cell resistance to apoptosis. Mol Cell Biol 29, 303-314.
4. Bonizzi G, Karin M (2004). The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25, 280-288. (Pubitemid 38610351)
5. Bonnard M et al. (2000). Defi ciency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J 19, 4976-4985.
6. Bradley JR, Pober JS (2001). Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20, 6482-6491.
7. Chen ZJ (2005). Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7, 758-765.
8. Chen ZJ, Sun LJ (2009). Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33, 275-286.
9. Csomos RA, Brady GF, Duckett CS (2009). Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2. J Biol Chem 284, 20531-20539.
10. Das M, Sabio G, Jiang F, Rincon M, Flavell RA, Davis RJ (2009). Induction of hepatitis by JNK-mediated expression of TNF-alpha. Cell 136, 249-260.
11. Davis RJ (2000). Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252.
12. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R, Franzoso G (2001). Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414, 308-313.
13. Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z (2000). The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12, 419-429.
14. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ (2006). Activation of IKK by TNFalpha requires site-specifi c ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22, 245-257.
15. Fan M, Goodwin M, Vu T, Brantley-Finley C, Gaarde WA, Chambers TC (2000). Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ ERK cascade. J Biol Chem 275, 29980-29985.
16. Gardam S, Sierro F, Basten A, Mackay F, Brink R (2008). TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 28, 391-401.
17. Grech AP, Amesbury M, Chan T, Gardam S, Basten A, Brink R (2004). TRAF2 differentially regulates the canonical and noncanonical pathways of NFkappaB activation in mature B cells. Immunity 21, 629-642.
18. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296.
19. Gwinner W, Landmesser U, Brandes RP, Kubat B, Plasger J, Eberhard O, Koch KM, Olbricht CJ (1997). Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. J Am Soc Nephrol 8, 1722-1731.
20. Habelhah H, Takahashi S, Cho SG, Kadoya T, Watanabe T, Ronai Z (2004). Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J 23, 322-332.
21. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell 100, 57-70.
22. Hayden MS, Ghosh S (2008). Shared principles in NF-kappaB signaling. Cell 132, 344-362.
23. Hoffmann A, Levchenko A, Scott ML, Baltimore D (2002). The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298, 1241-1245. (Pubitemid 35285493)
24. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M (2005). Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661.
25. Karin M, Cao Y, Greten FR, Li ZW (2002). NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2, 301-310.
26. Keats JJ et al. (2007). Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12, 131-144.
27. Ladner KJ, Caligiuri MA, Guttridge DC (2003). Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induced loss of skeletal muscle gene products. J Biol Chem 278, 2294-2303.
28. Leitges M, Sanz L, Martin P, Duran A, Braun U, Garcia JF, Camacho F, Diaz-Meco MT, Rennert PD, Moscat J (2001). Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol Cell 8, 771-780.
29. Liu H, Bigler SA, Henegar JR, Baliga R (2002). Cytochrome P450 2B1 mediates oxidant injury in puromycin-induced nephrotic syndrome. Kidney Int 62, 868-876.
30. Markou T, Dowling AA, Kelly T, Lazou A (2009). Regulation of Bcl-2 phosphorylation in response to oxidative stress in cardiac myocytes. Free Radic Res 43, 809-816.
31. Micheau O, Tschopp J (2003). Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181-190.
32. Moscat J, Diaz-Meco MT, Rennert P (2003). NF-kappaB activation by protein kinase C isoforms and B-cell function. EMBO Rep 4, 31-36.
33. Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K (2006). Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ 13, 730-737.
34. Noguchi T, Takeda K, Matsuzawa A, Saegusa K, Nakano H, Gohda J, Inoue J, Ichijo H (2005). Recruitment of tumor necrosis factor receptor-associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death. J Biol Chem 280, 37033-37040.
35. Orlowski RZ, Baldwin Jr AS (2002). NF-kappaB as a therapeutic target in cancer. Trends Mol Med 8, 385-389.
36. Sakon S et al. (2003). NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 22, 3898-3909.
37. Schmidt C, Peng B, Li Z, Sclabas GM, Fujioka S, Niu J, Schmidt-Supprian M, Evans DB, Abbruzzese JL, Chiao PJ (2003). Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation. Mol Cell 12, 1287-1300.
38. Shen HM, Lin Y, Choksi S, Tran J, Jin T, Chang L, Karin M, Zhang J, Liu ZG (2004). Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. Mol Cell Biol 24, 5914-5922.
39. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M, Lin A (2001). Inhibition of JNK activation through NF-kappaB target genes. Nature 414, 313-317.
40. Thomas GS, Zhang L, Blackwell K, Habelhah H (2009). Phosphorylation of TRAF2 within its RING domain inhibits stress-induced cell death by promoting IKK and suppressing JNK activation. Cancer Res 69, 3665-3672.
41. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H (2001). ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2, 222-228.
42. Vallabhapurapu S, Matsuzawa A, Zhang W, Tseng PH, Keats JJ, Wang H, Vignali DA, Bergsagel PL, Karin M (2008). Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol 9, 1364-1370.
43. Ventura JJ, Hubner A, Zhang C, Flavell RA, Shokat KM, Davis RJ (2006). Chemical genetic analysis of the time course of signal transduction by JNK. Mol Cell 21, 701-710.
44. Wajant H, Henkler F, Scheurich P (2001). The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 13, 389-400.
45. Werner SL, Barken D, Hoffmann A (2005). Stimulus specifi city of gene expression programs determined by temporal control of IKK activity. Science 309, 1857-1861.
46. Wong WW, Gentle IE, Nachbur U, Anderton H, Vaux DL, Silke J (2010). RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ 17, 482-487.
47. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006). Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol 8, 398-406.
48. Yamamoto K, Ichijo H, Korsmeyer SJ (1999). BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19, 8469-8478.
49. Yeh WC et al. (1997). Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-defi cient mice. Immunity 7, 715-725.
50. Zhang L, Blackwell K, Shi Z, Habelhah H (2010). The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB. J Mol Biol 396, 528-539.
51. Zhang L, Blackwell K, Thomas GS, Sun S, Yeh WC, Habelhah H (2009). TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells. J Mol Biol 389, 495-510.
52. Zhang SQ, Kovalenko A, Cantarella G, Wallach D (2000). Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 12, 301-311.